Ascletis Believes that the Complaints Made by Viking Therapeutics Have No Merit and will Vigorously Defend Against such Complaints
- Monday, January 2, 2023, 7:01
- Finance
- Add a comment
HANGZHOU and SHAOXING, China, Jan. 2, 2023 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”) was recently informed that on December 29, 2022, Viking Therapeutics, Inc. (“Viking”), a pharmaceutical company in the United States, filed certain complaints against Ascletis, its…
About the Author
adminasapcorp has written 39536 stories on this site.